Pharmacologic Substance
Zafirlukast
A tolyl compound and leukotriene receptor antagonist (LTRA), with anti-asthmatic and potential capsular contracture-preventing activities. Upon administration, zafirlukast selectively and competitively binds to and blocks the cysteinyl leukotriene 1 receptor (CYSLTR1), thereby preventing the potent...
more
Medscape
Accolate (zafirlukast) dosing, indications, interations, adverse effects, and more.
Viewing results
1 - 10 of 280,000 (0.25 seconds)
-
Dec 15, 2017 ... Zafirlukast is used to prevent asthma symptoms. Zafirlukast is in a class of medications called leukotriene receptor antagonists (LTRAs).
-
Feb 1, 2022 ... Zafirlukast is used to prevent asthma attacks. It is not used to relieve an attack that has already started. For relief of an asthma attack ...
-
Zafirlukast is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma, often used in conjunction with an inhaled steroid ...
-
Feb 1, 2022 ... Zafirlukast is used to prevent asthma attacks. It is not used to relieve an attack that has already started. For relief of an asthma attack that ...
-
Apr 9, 2020 ... This is a single-arm Simon two-stage phase 2 clinical trial to determine whether zafirlukast reduces the tumor marker CA-125 as well the ...
-
Zafirlukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma. Zafirlukast has ...
-
USES: Zafirlukast is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you ...
-
Mar 20, 2019 ... The cysteinyl leukotriene receptor 1 antagonists (CysLT1RA) montelukast, zafirlukast and pranlukast (Figure 1) were initially developed for the ...
-
Patients received a regimen of zafirlukast 20 mg by mouth 2 times daily for 3 months. Results. In many cases, dramatic softening of the breast capsule was ...
-
May 1, 2019 ... No published information is available on the use of zafirlukast during breastfeeding; however, manufacturer's data indicate that the dose in ...